Gemina Laboratories Stock Analysis

GLABF Stock  USD 0.84  0.04  5.00%   
Gemina Laboratories is overvalued with Real Value of 0.63 and Hype Value of 0.84. The main objective of Gemina Laboratories otc analysis is to determine its intrinsic value, which is an estimate of what Gemina Laboratories is worth, separate from its market price. There are two main types of Gemina Laboratories' stock analysis: fundamental analysis and technical analysis.
The Gemina Laboratories otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Gemina Laboratories' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gemina Laboratories. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Gemina OTC Stock Analysis Notes

About 56.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.08. Gemina Laboratories had not issued any dividends in recent years. Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.The quote for Gemina Laboratories is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Gemina Laboratories call the company at 604-760-1997 or check out https://www.geminalabs.com.

Gemina Laboratories Investment Alerts

Gemina Laboratories is way too risky over 90 days horizon
Gemina Laboratories has some characteristics of a very speculative penny stock
Gemina Laboratories appears to be risky and price may revert if volatility continues
Gemina Laboratories has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0.
Gemina Laboratories has accumulated about 2.95 M in cash with (3.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Roughly 56.0% of the company shares are held by company insiders

Gemina Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 33.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Gemina Laboratories's market, we take the total number of its shares issued and multiply it by Gemina Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 25th of March, Gemina Laboratories retains the Downside Deviation of 15.87, risk adjusted performance of 0.1481, and Market Risk Adjusted Performance of (3.86). Gemina Laboratories technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed nineteen technical drivers for Gemina Laboratories, which can be compared to its competitors. Please check out Gemina Laboratories maximum drawdown, semi variance, and the relationship between the jensen alpha and potential upside to decide if Gemina Laboratories is priced fairly, providing market reflects its last-minute price of 0.84 per share. Given that Gemina Laboratories is a hitting penny stock territory we urge to closely look at its total risk alpha.

Gemina Laboratories Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Gemina Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Gemina Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Gemina Laboratories Predictive Daily Indicators

Gemina Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Gemina Laboratories otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Gemina Laboratories Forecast Models

Gemina Laboratories' time-series forecasting models are one of many Gemina Laboratories' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gemina Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Gemina OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Gemina Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gemina shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Gemina Laboratories. By using and applying Gemina OTC Stock analysis, traders can create a robust methodology for identifying Gemina entry and exit points for their positions.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Gemina Laboratories to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Complementary Tools for Gemina OTC Stock analysis

When running Gemina Laboratories' price analysis, check to measure Gemina Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gemina Laboratories is operating at the current time. Most of Gemina Laboratories' value examination focuses on studying past and present price action to predict the probability of Gemina Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gemina Laboratories' price. Additionally, you may evaluate how the addition of Gemina Laboratories to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments